2023
Stephen Turnock, David R. Turton2, Carlos Daniel Martins1, Louis Chesler3

Thomas C Wilson , Véronique Gouverneur , Graham Smith , Gabriela Kramer‑Marek
Scientific Reports 10 20918 -20918

2020
PET of HER2-Positive Pulmonary Metastases with 18F-ZHER2:342 Affibody in a Murine Model of Breast Cancer: Comparison with 18F-FDG

G. Kramer-Marek , M. Bernardo , D. O. Kiesewetter , U. Bagci
The Journal of Nuclear Medicine 53 ( 6) 939 -946

29
2012
18F-ZHER2-Affibody: a new tracer for molecular imaging of HER2-expressing tumors by PET

Jacek Capala , Gabriela Kramer-Marek , Lucia Martiniova , Yesenia Rodriguez
Molecular Cancer Therapeutics 6

2007
Quantification of Gold Nanoparticles in Mouse Tissues Using Neutron Activation Analysis

Jacek Capala , Gabriela Kramer-Marek , Rachel S. Popelka-Filcoff , Elizabeth A. Mackey
Transactions of the American Nuclear Society 101 88 -89

2009
ANYL 96-Quantitation of gold in biological tissues using neutron activation analysis

Gabriela Kramer-Marek , Rachel Popelka-Filcoff , Elizabeth A Mackey , Rabia O Spatz
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 238

2009
Near-infrared photoimmunoTherapy (NIR-PIT) for the local control of solid cancers: challenges and potentials for human applications

Gabriela Kramer-Marek , Marta Barisa , Stefano Giuliani , Stefano Giuliani
Critical Reviews in Oncology Hematology 161 103325 -103325

2021
Quantification of HER2 degradation following 17-DMAG treatment by PET imaging

Gabriela Kramer-Marek , Yesenia Rodriguez , Dale O. Kiesewetter , Jacek Capala
Cancer Research 68 3179 -3179

2008
[18F]Fluoroform radiolabelling of the CHK1 inhibitor CCT245737

Gabriela Kramer-Marek , David Turton , Philip Miller , Graham Smith
Nuclear Medicine and Biology

2021
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.

Anu Puri , Gabriela Kramer-Marek , Ryan Campbell-Massa , Amichai Yavlovich
Journal of Liposome Research 18 ( 4) 293 -307

80
2008
Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.

Rafal Zielinski , Ilya Lyakhov , Amy Jacobs , Oleg Chertov
Journal of Immunotherapy 32 ( 8) 817 -825

52
2009
Near-infrared dual bioluminescence imaging in mouse models of cancer using infraluciferin

Cassandra L Stowe , Thomas A Burley , Helen Allan , Maria Vinci
eLife 8

40
2019
Molecular imaging in pancreatic cancer – A roadmap for therapeutic decisions

Gabriela Kramer-Marek , Jesse Gore , Murray Korc
Cancer Letters 341 ( 2) 132 -138

18
2013
Nanoscintillator conjugates as photodynamic therapy-based radiosensitizers: calculation of required physical parameters.

Nicole Y. Morgan , Gabriela Kramer-Marek , Paul D. Smith , Kevin Camphausen
Radiation Research 171 ( 2) 236 -244

59
2009
Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy

Makoto Mitsunaga , Takahito Nakajima , Kohei Sano , Gabriela Kramer-Marek
BMC Cancer 12 ( 1) 345 -345

101
2012
Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentation

Ulas Bagci , Gabriela Kramer-Marek , Daniel J Mollura
EJNMMI research 3 ( 1) 49 -49

12
2013
Developing a molecular imaging agent for Met using onartuzumab (MetMAb).

Cara Elizabeth Wright , Elaine Jagoda , Fabiola Cecchi , Veerendra Bhadrasetty
Journal of Clinical Oncology 31 ( 15_suppl) 11083 -11083

1
2013
Can PET Imaging Facilitate Optimization of Cancer Therapies

Gabriela Kramer-Marek , Jacek Capala
Current Pharmaceutical Design 18 ( 18) 2657 -2669

10
2012
1
2020
Radiosynthesis of the anticancer nucleoside analogue Trifluridine using an automated 18F-trifluoromethylation procedure

Alice King , Andreas Doepner , David Turton , Daniela M. Ciobota
Organic and Biomolecular Chemistry 16 ( 16) 2986 -2996

3
2018